arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Surgery Partners, Inc.

SGRY
$23.19 ▲ +0.03 (+0.13%) at close
Healthcare ·Services-General Medical & Surgical Hospitals, NEC ·USServices-General Medical & Surgical Hospitals, NEC
13 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Bearish
auto_awesome

Analytical Summary

Surgery Partners, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.9B
Dividend Yield —
Revenue Growth 6.2% ↘
Op. Margin 11.8% ↗
ROIC 5.6% ↗
FCF / Share $1.54 ↘
Trailing P/E —
Price / Book 1.8x
FCF Yield 6.6%
Debt / Equity 2.18
info Valuation on last close. End-of-day price, Nov 5, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.31B
↑ +6.2% —
Net Income Profit after all expenses
$-77.90M
↑ +53.7% —
Operating Margin Operating profit as % of sales
11.8%
↑ +5.1% 60th
FCF / Share Free cash flow per share
$1.54
↓ -7.5% —
Long-Term Debt Long-term obligations
$3.74B
↑ +9.7% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↑
45
Returns ↑
39
Financial Health ↓
34
Cash Quality ↓
6

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 47 quarters